ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.83
0.00%
US Tech 100
17,188.00
0.66%
S&P 500
5,064.20
0.91%
US Dollar vs CAD
1.36647
-0.02%
Bitcoin
59,163.27
0.07%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Pfizer Inc (PFE)

  7. Pfizer Inc (PFE) News

PFE

Pfizer (PFE)

Pfizer Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:PFE
DateTimeSourceHeadlineSymbolCompany
05/01/20248:12AMIH Market NewsCVS Health, Starbucks, Shares Weaker; Pinterest SoarsNYSE:PFEPfizer Inc
05/01/20245:45AMBusiness WirePfizer Reports First-Quarter 2024 ResultsNYSE:PFEPfizer Inc
04/29/20245:40PMBusiness WireTIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical CancerNYSE:PFEPfizer Inc
04/29/20245:40PMBusiness WireFDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical CancerNYSE:PFEPfizer Inc
04/29/20245:45AMBusiness WirePfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual MeetingNYSE:PFEPfizer Inc
04/26/20246:48AMIH Market NewsAnglo American Rejects BHP Group’s Offer, Toyota Invests $1.4 Billion in Indiana, and More NewsNYSE:PFEPfizer Inc
04/26/20245:45AMBusiness WireU.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia BNYSE:PFEPfizer Inc
04/24/20243:37PMBusiness WirePfizer Declares Second-Quarter 2024 DividendNYSE:PFEPfizer Inc
04/24/20246:28AMIH Market NewsCoca-Cola and Microsoft Sign Billion-Dollar Agreement, Apple Event Set for May 7, and More NewsNYSE:PFEPfizer Inc
04/22/20247:08AMBusiness WireEuropean Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment OptionsNYSE:PFEPfizer Inc
04/11/20249:00AMBusiness WirePfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25NYSE:PFEPfizer Inc
04/10/20246:13AMIH Market NewsDelta Generates US$37 Million Profit in Q1, Google and Intel Unveil Cutting-Edge AI Chips, and More NewsNYSE:PFEPfizer Inc
04/09/20245:45AMBusiness WirePfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV DiseaseNYSE:PFEPfizer Inc
04/08/202411:44AMPR Newswire (US)ALTIVIA Appoints Scott Barnum as Director of Manufacturing and Dean Hale as Corporate Engineering ManagerNYSE:PFEPfizer Inc
03/26/20246:20AMIH Market NewsSuper Micro Computer and Seagate Shares Surge on Analyst Optimism in Pre-Market Trading, and Latest NewsNYSE:PFEPfizer Inc
03/21/20246:17AMIH Market NewsApple Pre-Market Drop Due to Antitrust Threats, Surprising Profit Boosts Micron Shares, and Latest Market UpdatesNYSE:PFEPfizer Inc
03/20/20249:00AMBusiness WirePfizer Invites Public to View and Listen to Webcast of May 1 Conference Call with AnalystsNYSE:PFEPfizer Inc
03/19/20246:33AMIH Market NewsUnilever Initiates Ice Cream Division Spin-Off and Announces Job Cuts; Berkshire Ramps Up Share Buyback Efforts, and MoreNYSE:PFEPfizer Inc
03/18/20246:10AMIH Market NewsApple & Google in Talks for Gemini AI on iPhone, Nvidia’s GTC Conference Today, and Latest NewsNYSE:PFEPfizer Inc
03/13/20243:00AMBusiness WireEuropean Commission Approves Pfizer’s PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal DiseaseNYSE:PFEPfizer Inc
03/12/20245:45AMBusiness WirePfizer Announces Positive Overall Survival in Phase 3 Trial of ADCETRIS® Regimen in Patients with Relapsed/​Refractory Diffuse Large B-cell Lymphoma (DLBCL)NYSE:PFEPfizer Inc
03/05/20242:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
03/05/20249:00AMBusiness WirePfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare ConferenceNYSE:PFEPfizer Inc
03/05/20248:03AMIH Market NewsFutures Pointing To Continued Weakness On Wall StreetNYSE:PFEPfizer Inc
03/01/202412:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
02/29/20244:40PMBusiness WirePfizer Oncology Hosts Innovation Day, Highlighting Fully Integrated Organization, Robust Portfolio, and Strategic Priorities to Drive Long-Term Sustainable GrowthNYSE:PFEPfizer Inc
02/29/20247:00AMBusiness WirePfizer Announces Positive Top-Line Data for Full Season Two Efficacy of ABRYSVO® for RSV in Older AdultsNYSE:PFEPfizer Inc
02/28/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
02/28/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
02/28/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
 Showing the most relevant articles for your search:NYSE:PFE

Your Recent History

NASDAQ
JAGX
Jaguar Health
USOTC
VPLM
Voip Pal Com (QB)
USOTC
BEGI
BlackStar Enterprise (PK)
USOTC
GDVM
Global Developments (PK)
USOTC
BMXI
Brookmount Explorations (PK)
USOTC
SPZI
Spooz (PK)
USOTC
CBDD
CBD of Denver (PK)
USOTC
BLLB
Bell Buckle (PK)
NASDAQ
DJT
Trump Media and Technology
USOTC
GSTC
Globestar Therapeutics (PK)
USOTC
ILST
International Star (PK)
USOTC
TSOI
Therapeutic Solutions (PK)
USOTC
ACRL
Atacama Resources (PK)
NASDAQ
AMRN
Amarin
NASDAQ
MULN
Mullen Automotive
USOTC
SHMP
NaturalShrimp (QB)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved